# A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL

> **NCT03494296** · — · RECRUITING · sponsor: **First Affiliated Hospital of Harbin Medical University** · enrollment: 150 (estimated)

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** patients received D-COP regimen chemotherapy

## Key facts

- **NCT ID:** NCT03494296
- **Lead sponsor:** First Affiliated Hospital of Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-03-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2018-04-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03494296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03494296, "A Prospective Study of Low-dose Decitabine Combined With COP Regimen in the Treatment of Relapsed and Refractory DLBCL". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03494296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*